Charles River Laboratories International Inc.

Sector and Industry

Healthcare, Healthcare Services

Performance (1Y)

44.90%

Market Cap

9.28 Bil.

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-2.58 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
UnitedHealth Group Inc.254.66 Bil.396.73 Bil.24.94
-19.75 %
0.00
-
Thermo Fisher Scientific Inc.185.62 Bil.39.50 Bil.32.67
+1.45 %
0.00
-
Danaher Corp.137.79 Bil.21.78 Bil.45.36
-11.47 %
0.00
-
McKesson Corporation90.13 Bil.348.09 Bil.22.55
+33.83 %
0.00
-
HCA Healthcare Inc.89.28 Bil.67.01 Bil.16.48
+12.93 %
0.00
-
Elevance Health Inc.65.88 Bil.176.51 Bil.13.91
-9.22 %
0.00
-
The Cigna Group61.74 Bil.243.65 Bil.12.41
+66.33 %
0.00
-
Cencora Inc.51.58 Bil.291.15 Bil.39.26
+1.16 %
0.00
-
IDEXX Laboratories Inc.45.92 Bil.3.81 Bil.51.74
+14.41 %
0.00
-
Zoetis Inc.45.52 Bil.8.39 Bil.20.89
+3.10 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE192.5 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 11:18:31 AM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW192.5192.15
PREV. DAY'S PRICE192.65 (07/20)
CHANGE DAY BEFORE
-0.15
-0.08 %
52 WEEK HIGH / LOW207.1 (07/01)124.05 (09/25)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
8.530.18-2.589.7010.75
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
25.63933.6019.40(e)20.2118.24
PRICE - BOOK RATIO
3.372.753.17--
PRICE - SALES RATIO
2.952.372.51--
PRICE - CASH FLOW RATIO
17.7813.0813.68--
Further Key Figures

Master Data

WKN
939391
ISIN
US1598641074
SYMBOL
RV6
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Charles River Laboratories
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Healthcare Services
NUMBER OF SHARES
48.17 Mil.
MARKET CAPITALISATION
9.28 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-4.20 %
20.26 %
22.43 %
3.63 %
44.90 %
5.82 %
-40.54 %
12.33 %
HIGH205.20207.10207.10207.10207.10251.90390.00207.10
LOW189.40155.95127.20127.20124.0588.0488.04127.20

Dividende

pro Aktie
Charles River Laboratories does not deliver dividend information

Company profile

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The Discovery and Safety Assessment segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.